Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group
Abstract
Trovafloxacin given once daily for 5 days was clinically and bacteriologically equivalent to doxycycline given twice daily for 7 days in women with uncomplicated chlamydial cervicitis. This equivalence was not demonstrated in men with uncomplicated chlamydial urethritis.
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
adult
female
male
adolescent
aged
middle aged
Comparative Study
sex factors
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Multicenter Study
anti-bacterial agents / adverse effects
fluoroquinolones*
anti-bacterial agents / administration & dosage
anti-bacterial agents / therapeutic use*
chlamydia infections / drug therapy*
doxycycline / adverse effects
doxycycline / therapeutic use*
pmid:10534208
doi:10.1097/00007435-199910000-00009
w m mccormack
z a dalu
r b johnson
anti-infective agents / adverse effects
anti-infective agents / therapeutic use*
chlamydia trachomatis*
doxycycline / administration & dosage
naphthyridines / adverse effects
naphthyridines / therapeutic use*
urethritis / drug therapy*
urethritis / microbiology
uterine cervicitis / drug therapy*
uterine cervicitis / microbiology
Access
Citation
ID:
112866
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
112866
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet